$PCAR — WATCHLIST 📊 | 6 MONTHS THESIS

$PCAR — WATCHLIST 📊 | 6 MONTHS THESIS 🎯 Q1 2026 | Rev $6.8B | EPS $1.15 vs $1.15 ➖ 💡 Consensus sees stable $4.50–$5.00 EPS and a 22–24x multiple as fair. Our variant: mid-cycle EPS is closer to $4.00–$4.50, and the multiple will revert toward 16–20x as the cycle ages, implying fair value ~$90–100. The market is underappreciating cyclical risk. 📉 Reward/risk: 4.75:1 🏢 Business Quality: 8/10 📊 Valuation: rich — trailing P/E 25.9x, forward ~24x vs. 10-year median 14–16x and heavy-truck peers at 12–15x; reverse DCF implies 4%+ perpetual growth to... 🔮 Catalyst: ACT Research Class 8 orders data or Q2 earnings pre-announcement 💰 Entry: $100, stop $92, target $130 ⚖️ Watchlist — PACCAR is a premier industrial compounder, but at 24x+ P/E it prices in peak cycle; wait for a pullback to ~$100 for a 4.75:1 risk/reward entry. 📊 Our read: WATCHLIST. Full analysis → https://stockduty.xyz/s/PCAR0620

🎯 Q1 2026 | Rev $6.8B | EPS $1.15 vs $1.15 ➖